Position in NVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,180,454
+$706,890 QoQ
Shares Held
45,483
+13.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#364
of 1,348 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OVERSEA-CHINESE BANKING Corp Ltd holds $49,906,506 across 10 Drug Manufacturers - General names. NVO ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,672 | $21,196,327 | |
| 2 | BIIB |
Biogen Inc.
|
31,867 | $6,885,184 | |
| 3 | JNJ |
Johnson & Johnson
|
20,127 | $5,111,653 | |
| 4 | MRK |
Merck & Co., Inc.
|
37,333 | $4,797,290 | |
| 5 | ABBV |
AbbVie Inc.
|
13,597 | $3,421,549 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
45,483 | $2,180,454 | |
| 7 | PFE |
Pfizer Inc
|
83,573 | $2,012,437 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
14,265 | $1,802,239 |
All Filings in NVO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,180,454 | 45,483 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $1,473,564 | 40,097 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,024,510 | 59,444 | Shares | Sole | 2026-04-28 | |
| 2025-09-30 | $757,937 | 13,659 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $1,209,989 | 17,531 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $2,047,091 | 29,480 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,752,743 | 20,376 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,223,443 | 10,275 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $929,665 | 6,513 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $901,753 | 7,023 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||